,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,5,22.0,Death,16281363
0,2,22.0,Dermatitis acneiform,16281378
0,3,22.0,Fatigue,16281386
1,6,22.0,Haemoglobin decreased,16281386
2,6,22.0,Infection,16281386
3,6,22.0,Fall,16281386
4,6,22.0,White blood cell count decreased,16281386
5,3,22.0,Decreased appetite,16281386
0,1,22.0,General physical health deterioration,16281391
0,1,22.0,Blood creatinine increased,16281416
1,1,22.0,Renal disorder,16281416
2,6,22.0,Ear pain,16281416
3,1,22.0,Sinusitis,16281416
4,1,22.0,Toothache,16281416
5,1,22.0,White blood cell count decreased,16281416
0,6,22.0,Dyspnoea,16281469
1,3,22.0,Lymphoedema,16281469
0,3,22.0,Fatigue,16281484
1,6,22.0,Asthenia,16281484
2,6,22.0,Rheumatoid arthritis,16281484
3,6,22.0,Cognitive disorder,16281484
4,6,22.0,Arthralgia,16281484
5,6,22.0,Hypoaesthesia,16281484
6,6,22.0,Neoplasm progression,16281484
7,6,22.0,Panic attack,16281484
8,6,22.0,Nausea,16281484
9,6,22.0,Pain in extremity,16281484
10,6,22.0,Pharyngeal paraesthesia,16281484
0,2,22.0,Myelopathy,16281543
1,2,22.0,Peripheral motor neuropathy,16281543
0,3,22.0,Nail disorder,16281684
1,3,22.0,Fatigue,16281684
2,3,22.0,Alopecia,16281684
0,6,22.1,Optic ischaemic neuropathy,16281699
1,6,22.1,Malaise,16281699
2,6,22.1,Product dose omission,16281699
0,3,22.1,Disturbance in attention,16281702
1,3,22.1,Fatigue,16281702
0,6,22.0,Diarrhoea,16281762
1,2,22.0,Interstitial lung disease,16281762
2,6,22.0,Vomiting,16281762
0,2,22.1,Decreased appetite,16281774
1,2,22.1,Diarrhoea,16281774
2,5,22.1,Death,16281774
3,2,22.1,Asthenia,16281774
4,3,22.1,Oral discomfort,16281774
5,2,22.1,Vomiting,16281774
6,3,22.1,Dry mouth,16281774
7,6,22.1,Fatigue,16281774
8,2,22.1,Oedema peripheral,16281774
9,2,22.1,Dehydration,16281774
0,6,22.0,Off label use,16281804
1,6,22.0,Product use in unapproved indication,16281804
2,6,22.0,Asthenia,16281804
0,6,22.0,Coronary artery occlusion,16281836
1,5,22.0,Myocardial infarction,16281836
2,6,22.0,Dyspnoea,16281836
3,5,22.0,Dyspnoea,16281836
4,5,22.0,Fall,16281836
5,6,22.0,Ventricular tachycardia,16281836
6,6,22.0,Pericardial effusion,16281836
7,6,22.0,Medical device site haemorrhage,16281836
8,6,22.0,Asthenia,16281836
0,3,22.0,Rhinitis,16281839
1,3,22.0,Onychoclasis,16281839
2,6,22.0,Hypoaesthesia,16281839
3,3,22.0,Madarosis,16281839
4,3,22.0,Pigmentation disorder,16281839
5,6,22.0,Sensory disturbance,16281839
6,3,22.0,Lacrimation increased,16281839
7,6,22.0,Polyneuropathy,16281839
8,3,22.0,Dry skin,16281839
0,3,22.0,Disease progression,16281869
1,3,22.0,Nausea,16281869
2,3,22.0,Weight decreased,16281869
3,3,22.0,Decreased appetite,16281869
0,6,22.0,Neutropenia,16281898
0,2,22.0,Lactic acidosis,16281915
1,2,22.0,Hyperammonaemia,16281915
2,2,22.0,Encephalopathy,16281915
0,5,22.0,Death,16281920
1,6,22.0,Inappropriate schedule of product administration,16281920
0,5,22.0,Death,16281924
0,3,22.0,Respiratory failure,16281926
1,3,22.0,Cardiac failure,16281926
2,3,22.0,Ejection fraction decreased,16281926
0,1,22.0,Nausea,16281942
1,1,22.0,Diarrhoea,16281942
2,1,22.0,Faeces discoloured,16281942
3,1,22.0,Feeding disorder,16281942
4,1,22.0,Headache,16281942
5,1,22.0,Abdominal distension,16281942
6,1,22.0,Flatulence,16281942
0,1,22.0,Anal incontinence,16281945
1,1,22.0,Hyponatraemia,16281945
2,1,22.0,Dizziness,16281945
3,1,22.0,Electrolyte imbalance,16281945
0,3,22.0,Osteolysis,16281968
1,3,22.0,Neutropenia,16281968
2,3,22.0,Bone pain,16281968
0,2,22.0,Platelet count decreased,16281969
1,2,22.0,Immunosuppression,16281969
2,2,22.0,Malignant neoplasm progression,16281969
3,6,22.0,White blood cell count increased,16281969
4,2,22.0,Metastases to liver,16281969
5,2,22.0,Meningoencephalitis herpetic,16281969
6,2,22.0,Protein total increased,16281969
7,2,22.0,Metastases to central nervous system,16281969
8,2,22.0,Headache,16281969
9,2,22.0,Asthenia,16281969
10,6,22.0,Herpes simplex encephalitis,16281969
11,2,22.0,Breast cancer,16281969
12,2,22.0,Metastases to eye,16281969
0,6,22.0,Breast cancer metastatic,16281970
1,6,22.0,Metastases to liver,16281970
0,6,22.0,Breast cancer,16281971
1,6,22.0,Metastases to liver,16281971
2,6,22.0,Malignant neoplasm progression,16281971
3,6,22.0,Metastases to meninges,16281971
0,6,22.0,Dyspnoea,16281975
1,6,22.0,Muscle fatigue,16281975
0,2,22.0,Syncope,16281992
1,2,22.0,Hyperglycaemia,16281992
2,1,22.0,Pneumonia influenzal,16281992
3,2,22.0,Type 2 diabetes mellitus,16281992
4,1,22.0,Myopathy,16281992
0,1,22.0,Lung infection,16281996
1,1,22.0,Chills,16281996
0,3,22.0,Corneal infiltrates,16281998
0,1,22.0,Pain,16282023
0,3,22.0,Immune thrombocytopenic purpura,16282101
0,5,22.0,Death,16282102
0,1,22.0,Adrenal insufficiency,16282270
1,1,22.0,Neutropenia,16282270
0,6,22.0,Drug ineffective,16282307
1,3,22.0,Pemphigoid,16282307
0,6,22.0,Erythema,16282309
1,6,22.0,Hypotension,16282309
2,6,22.0,Hypothermia,16282309
0,2,22.0,Hypomagnesaemia,16282322
1,2,22.0,Hypokalaemia,16282322
2,1,22.0,Diarrhoea,16282322
3,2,22.0,Hypophosphataemia,16282322
0,3,22.0,Hot flush,16282342
1,1,22.0,Diarrhoea infectious,16282342
2,6,22.0,White blood cell count decreased,16282342
3,3,22.0,Alanine aminotransferase increased,16282342
4,3,22.0,Stomatitis,16282342
5,3,22.0,Nausea,16282342
6,1,22.0,Neutropenia,16282342
7,6,22.0,Neutrophil count decreased,16282342
0,6,22.0,Insomnia,16282351
1,3,22.0,Hypertension,16282351
2,6,22.0,Malaise,16282351
3,3,22.0,Diabetes mellitus,16282351
4,3,22.0,Dry eye,16282351
5,6,22.0,Headache,16282351
6,6,22.0,Body temperature increased,16282351
7,6,22.0,Arthralgia,16282351
0,6,22.0,Lung cancer metastatic,16282352
1,6,22.0,Product use in unapproved indication,16282352
2,6,22.0,Neutropenia,16282352
3,6,22.0,Malignant neoplasm progression,16282352
0,6,22.0,Neutropenic sepsis,16282400
1,6,22.0,Malaise,16282400
2,1,22.0,Thrombocytopenia,16282400
0,6,22.0,Alopecia,16282472
1,6,22.0,Fatigue,16282472
2,6,22.0,Bone pain,16282472
3,6,22.0,Dizziness,16282472
4,6,22.0,Mouth ulceration,16282472
5,6,22.0,Stomatitis,16282472
0,6,22.0,Neutrophil count decreased,16282478
0,6,22.0,Haemoglobin decreased,16282481
1,6,22.0,Platelet count decreased,16282481
0,3,22.0,Feeding disorder,16282483
1,3,22.0,Weight decreased,16282483
2,6,22.0,Fatigue,16282483
3,3,22.0,Malaise,16282483
4,3,22.0,Oral pain,16282483
0,6,22.0,Dehydration,16282499
1,6,22.0,Product use issue,16282499
2,6,22.0,Product dose omission,16282499
3,3,22.0,Brain neoplasm malignant,16282499
4,6,22.0,Blood calcium increased,16282499
5,6,22.0,Metastases to pelvis,16282499
6,6,22.0,Off label use,16282499
0,1,22.0,Alanine aminotransferase increased,16282501
1,1,22.0,Aspartate aminotransferase increased,16282501
2,1,22.0,Hepatocellular injury,16282501
0,5,22.0,Death,16282571
0,2,22.0,Nausea,16282605
1,2,22.0,Vomiting,16282605
2,3,22.0,Feeding disorder,16282605
0,6,22.0,Pyrexia,16282614
1,2,22.0,Leukopenia,16282614
0,1,22.0,Large intestinal obstruction,16282783
1,1,22.0,Peripheral sensory neuropathy,16282783
0,2,22.0,Neuropathy peripheral,16282994
1,2,22.0,Palmar-plantar erythrodysaesthesia syndrome,16282994
2,2,22.0,Nail disorder,16282994
0,2,22.0,Ascites,16283006
1,6,22.0,Product use in unapproved indication,16283006
0,3,22.0,Hot flush,16283012
1,3,22.0,Memory impairment,16283012
0,6,22.0,Inappropriate schedule of product administration,16283118
1,6,22.0,Malignant neoplasm progression,16283118
2,6,22.0,Skin lesion,16283118
3,6,22.0,Breast cancer stage III,16283118
4,6,22.0,Dermatitis,16283118
5,6,22.0,Metastases to skin,16283118
6,6,22.0,Therapeutic response decreased,16283118
0,2,22.0,Disorganised speech,16283148
1,2,22.0,Psychiatric symptom,16283148
2,2,22.0,Dysphoria,16283148
3,2,22.0,Suicidal ideation,16283148
0,6,22.0,Lacrimation increased,16283190
1,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16283190
2,6,22.0,Mucosal inflammation,16283190
0,4,22.0,Retinopathy,16283203
0,6,22.0,Decreased immune responsiveness,16283227
1,6,22.0,Pericardial effusion,16283227
2,6,22.0,Pleural effusion,16283227
0,1,22.0,Confusional state,16283261
1,1,22.0,Gastroenteritis norovirus,16283261
0,6,22.0,Malignant neoplasm progression,16283367
0,4,22.0,Food poisoning,16283375
0,6,22.0,Anxiety,16283411
1,6,22.0,Impaired quality of life,16283411
2,3,22.0,Alopecia,16283411
3,6,22.0,Emotional distress,16283411
4,6,22.0,Pain,16283411
5,6,22.0,Psychological trauma,16283411
0,2,22.1,Alopecia,16283412
1,6,22.1,Impaired quality of life,16283412
2,6,22.1,Psychological trauma,16283412
3,6,22.1,Anxiety,16283412
4,6,22.1,Emotional distress,16283412
5,6,22.1,Pain,16283412
0,2,22.0,Alopecia,16283414
0,6,22.0,Psychological trauma,16283415
1,2,22.0,Alopecia,16283415
0,6,22.0,Emotional distress,16283418
1,3,22.0,Alopecia,16283418
2,6,22.0,Impaired quality of life,16283418
3,6,22.0,Anxiety,16283418
4,6,22.0,Pain,16283418
0,6,22.0,Asthenia,16283452
1,6,22.0,Drug ineffective,16283452
2,6,22.0,Product use in unapproved indication,16283452
0,6,22.0,Neoplasm progression,16283465
0,6,22.0,Psychological trauma,16283473
1,2,22.0,Alopecia,16283473
0,3,22.0,Alopecia,16283474
1,6,22.0,Psychological trauma,16283474
0,2,22.0,Alopecia,16283475
0,6,22.0,Psychological trauma,16283476
1,2,22.0,Alopecia,16283476
0,3,22.0,Alopecia,16283477
1,6,22.0,Psychological trauma,16283477
0,3,22.0,Alopecia,16283479
1,6,22.0,Psychological trauma,16283479
0,2,22.0,Alopecia,16283484
1,6,22.0,Psychological trauma,16283484
0,3,22.0,Alopecia,16283485
1,6,22.0,Psychological trauma,16283485
0,2,22.0,Alopecia,16283486
0,2,22.0,Alopecia,16283487
0,3,22.0,Alopecia,16283490
0,2,22.0,Alopecia,16283491
0,2,22.0,Alopecia,16283493
1,6,22.0,Psychological trauma,16283493
0,3,22.1,Alopecia,16283495
0,2,22.0,Alopecia,16283497
1,6,22.0,Psychological trauma,16283497
0,6,22.0,Psychological trauma,16283498
1,3,22.0,Alopecia,16283498
0,2,22.1,Alopecia,16283499
1,6,22.1,Psychological trauma,16283499
0,6,22.0,Alopecia,16283500
1,6,22.0,Psychological trauma,16283500
0,6,22.0,Psychological trauma,16283503
1,2,22.0,Alopecia,16283503
0,6,22.0,Abortion,16283519
1,6,22.0,Exposure via partner,16283519
0,2,22.0,Alopecia,16283547
1,6,22.0,Psychological trauma,16283547
0,6,22.1,Psychological trauma,16283555
1,3,22.1,Alopecia,16283555
0,3,22.0,Alopecia,16283566
1,6,22.0,Psychological trauma,16283566
0,1,22.0,Nephrolithiasis,16283585
0,5,22.0,Death,16283596
1,6,22.0,Product use in unapproved indication,16283596
0,1,22.0,Gastrointestinal perforation,16283826
0,6,22.0,Leukopenia,16283856
1,2,22.0,Liver function test increased,16283856
2,6,22.0,Decreased appetite,16283856
3,5,22.0,Death,16283856
0,1,22.0,Dehydration,16283881
1,3,22.0,Headache,16283881
2,6,22.0,Dry mouth,16283881
3,3,22.0,Feeling abnormal,16283881
4,3,22.0,Abdominal discomfort,16283881
5,3,22.0,Vomiting,16283881
6,3,22.0,Fatigue,16283881
7,3,22.0,Taste disorder,16283881
8,3,22.0,Eating disorder,16283881
9,3,22.0,Weight decreased,16283881
10,6,22.0,Pulmonary congestion,16283881
11,6,22.0,Blood pressure fluctuation,16283881
12,6,22.0,Lung infection,16283881
13,6,22.0,Thyroid function test abnormal,16283881
0,6,22.0,Neutropenia,16283946
0,1,22.0,Neutropenia,16283948
0,6,22.0,Hepatotoxicity,16283958
1,6,22.0,Diarrhoea,16283958
2,6,22.0,Fatigue,16283958
3,6,22.0,Bronchial obstruction,16283958
4,6,22.0,Off label use,16283958
0,5,22.0,Death,16283960
0,5,22.0,Death,16283963
0,5,22.0,Hepatitis fulminant,16283985
0,6,22.0,Fatigue,16284037
1,6,22.0,Thyroid dermatopathy,16284037
2,6,22.0,Atrial flutter,16284037
3,6,22.0,Malaise,16284037
4,6,22.0,Dizziness,16284037
5,6,22.0,Tachycardia,16284037
6,6,22.0,Epistaxis,16284037
7,6,22.0,Anaemia,16284037
8,2,22.0,Hyperthyroidism,16284037
0,5,22.0,Respiratory failure,16284040
1,5,22.0,Diarrhoea,16284040
2,5,22.0,Epilepsy,16284040
3,5,22.0,Febrile neutropenia,16284040
4,5,22.0,Mucosal inflammation,16284040
5,5,22.0,Cardiogenic shock,16284040
6,5,22.0,Atrial fibrillation,16284040
7,5,22.0,Septic shock,16284040
8,5,22.0,Cardiac failure,16284040
9,6,22.0,Respiratory tract infection,16284040
10,6,22.0,Toxicity to various agents,16284040
11,5,22.0,Multiple organ dysfunction syndrome,16284040
12,5,22.0,Pancytopenia,16284040
13,5,22.0,Thrombocytopenia,16284040
0,1,22.0,Blood pressure decreased,16284050
1,1,22.0,Feeling abnormal,16284050
2,1,22.0,Suffocation feeling,16284050
3,1,22.0,Asthenia,16284050
4,1,22.0,Heart rate increased,16284050
5,1,22.0,Dyspnoea,16284050
0,2,22.0,Dysphonia,16284056
1,6,22.0,Blood pressure increased,16284056
2,2,22.0,Chromaturia,16284056
3,2,22.0,Dehydration,16284056
0,6,22.0,Swelling,16284068
1,6,22.0,Fluid retention,16284068
2,6,22.0,Blood bilirubin increased,16284068
0,3,22.1,Neutropenia,16284077
1,5,22.1,Pneumonia aspiration,16284077
0,1,22.0,Dehydration,16284084
0,2,22.0,Pericardial effusion,16284260
1,6,22.0,Uterine leiomyoma,16284260
2,6,22.0,Uterine neoplasm,16284260
3,6,22.0,Lacunar infarction,16284260
4,6,22.0,Hypotonia,16284260
5,6,22.0,Diarrhoea,16284260
6,6,22.0,Pneumonitis,16284260
0,2,22.0,Encephalitis,16284270
1,3,22.0,Sinusitis,16284270
2,3,22.0,Cough,16284270
3,6,22.0,Skin papilloma,16284270
4,6,22.0,Peripheral swelling,16284270
5,6,22.0,Rash,16284270
6,1,22.0,Pruritus,16284270
7,6,22.0,Weight increased,16284270
0,5,22.0,Malignant neoplasm progression,16284295
0,2,22.0,Gastrointestinal toxicity,16284399
1,2,22.0,Nausea,16284399
2,2,22.0,Vomiting,16284399
0,1,22.0,Sleep disorder,16284447
1,1,22.0,Nervousness,16284447
2,6,22.0,Osteoporosis,16284447
3,2,22.0,Pruritus,16284447
4,6,22.0,Blood pressure abnormal,16284447
0,1,22.0,Device kink,16284450
0,6,22.0,Metastases to bone,16284486
1,6,22.0,Breast cancer metastatic,16284486
2,6,22.0,Malignant neoplasm progression,16284486
0,6,22.0,Disease recurrence,16284488
1,6,22.0,Haematotoxicity,16284488
2,6,22.0,Peritonitis,16284488
0,1,22.0,Febrile neutropenia,16284496
1,1,22.0,Neutropenia,16284496
0,1,22.0,Pain,16284504
1,1,22.0,Cellulitis,16284504
2,1,22.0,Neutropenia,16284504
3,1,22.0,Vomiting,16284504
4,1,22.0,Diarrhoea,16284504
5,1,22.0,Cystitis,16284504
6,1,22.0,Dyspepsia,16284504
7,1,22.0,Nausea,16284504
8,1,22.0,Hypophagia,16284504
0,6,22.0,Decreased appetite,16284529
1,6,22.0,Nausea,16284529
2,6,22.0,Anaemia,16284529
3,6,22.0,Leukopenia,16284529
4,6,22.0,Proteinuria,16284529
0,4,22.1,Cerebral infarction,16284536
0,5,22.0,Malignant neoplasm progression,16284550
0,3,22.0,Neuropathy peripheral,16284560
1,3,22.0,Pain,16284560
2,3,22.0,Paraesthesia,16284560
3,3,22.0,Flatulence,16284560
0,1,22.0,Pneumonia,16284576
0,6,22.0,Neoplasm recurrence,16284624
0,6,22.0,Drug resistance,16284641
0,6,22.0,Off label use,16284649
1,3,22.0,Aphasia,16284649
2,3,22.0,Encephalopathy,16284649
0,6,22.0,Pathological fracture,16284709
1,6,22.0,Neoplasm progression,16284709
2,6,22.0,Femur fracture,16284709
3,6,22.0,Metastases to bone,16284709
0,6,22.0,Adverse event,16284770
0,1,22.0,Blood lactate dehydrogenase increased,16284786
1,1,22.0,Rhabdomyolysis,16284786
2,1,22.0,Blood creatine phosphokinase increased,16284786
3,1,22.0,Hyperkalaemia,16284786
4,1,22.0,Acute kidney injury,16284786
5,1,22.0,Malaise,16284786
6,1,22.0,Asthenia,16284786
7,1,22.0,Gait disturbance,16284786
8,1,22.0,Myalgia,16284786
0,1,22.0,Female genital tract fistula,16284813
0,6,22.1,Hydronephrosis,16284816
1,1,22.1,Vomiting,16284816
2,6,22.1,Malignant neoplasm progression,16284816
3,6,22.1,Ureteritis,16284816
0,6,22.0,Off label use,16284862
0,6,22.0,Cardiac failure,16284891
1,6,22.0,Malaise,16284891
2,6,22.0,Product use issue,16284891
3,6,22.0,Swelling face,16284891
4,6,22.0,Peripheral swelling,16284891
5,6,22.0,Dizziness,16284891
0,1,22.0,Prostatic haemorrhage,16284916
1,1,22.0,Atrial fibrillation,16284916
2,1,22.0,Blood loss anaemia,16284916
0,2,22.0,Vascular device infection,16284927
1,2,22.0,Staphylococcal infection,16284927
0,6,22.0,Hepatic enzyme increased,16284972
1,6,22.0,Neuropathy peripheral,16284972
2,6,22.0,Febrile neutropenia,16284972
3,6,22.0,Asthenia,16284972
4,6,22.0,Ejection fraction decreased,16284972
5,6,22.0,Thrombocytopenia,16284972
6,6,22.0,Alopecia,16284972
7,6,22.0,Mucosal inflammation,16284972
8,6,22.0,Hypocalcaemia,16284972
9,6,22.0,Nausea,16284972
10,6,22.0,Arthralgia,16284972
11,6,22.0,Lacrimation decreased,16284972
12,6,22.0,Rash,16284972
13,6,22.0,Neutropenia,16284972
14,6,22.0,Hyperbilirubinaemia,16284972
15,6,22.0,Cough,16284972
16,6,22.0,Diarrhoea,16284972
17,6,22.0,Hypersensitivity,16284972
18,6,22.0,Myalgia,16284972
0,3,22.0,Fracture,16284978
0,6,22.0,Malignant neoplasm progression,16285026
0,2,22.0,Hypercalcaemia,16285036
0,6,22.0,Viral upper respiratory tract infection,16285037
1,6,22.0,Pyrexia,16285037
0,5,22.0,Death,16285042
1,6,22.0,Malignant neoplasm progression,16285042
0,1,22.0,Diarrhoea,16285076
1,1,22.0,Lactic acidosis,16285076
2,1,22.0,Acute kidney injury,16285076
0,1,22.0,Paraesthesia,16285120
1,1,22.0,Balance disorder,16285120
2,1,22.0,Nausea,16285120
3,1,22.0,Vomiting,16285120
0,2,22.0,Acute kidney injury,16285143
1,2,22.0,Hyperkalaemia,16285143
0,1,22.0,Cardiogenic shock,16285152
1,1,22.0,Cardiac failure,16285152
2,6,22.0,Neoplasm progression,16285152
3,6,22.0,Therapy partial responder,16285152
0,6,22.0,PIK3CA-activated mutation,16285164
0,6,22.0,Foaming at mouth,16285173
1,6,22.0,Vomiting,16285173
2,6,22.0,Asthenia,16285173
3,6,22.0,Product use in unapproved indication,16285173
4,6,22.0,Ageusia,16285173
5,5,22.0,Death,16285173
6,6,22.0,Eating disorder,16285173
7,6,22.0,Malignant neoplasm progression,16285173
8,6,22.0,Fear,16285173
9,6,22.0,Malaise,16285173
10,6,22.0,Gait disturbance,16285173
0,1,22.0,Pancytopenia,16285178
1,1,22.0,Acute kidney injury,16285178
0,6,22.0,Hyperthyroidism,16285193
1,1,22.0,Hyperthyroidism,16285193
2,6,22.0,Thyroid dermatopathy,16285193
3,6,22.0,Anaemia,16285193
4,6,22.0,Atrial flutter,16285193
5,2,22.0,Thyroiditis,16285193
6,6,22.0,Epistaxis,16285193
0,6,22.0,Therapeutic response decreased,16285226
0,5,22.0,Death,16285264
0,,22.0,Nausea,16285271
1,,22.0,Dehydration,16285271
2,,22.0,Abdominal pain,16285271
3,,22.0,Blood electrolytes abnormal,16285271
4,,22.0,Vomiting,16285271
5,,22.0,Gastroenteritis,16285271
0,6,22.1,Intentional product use issue,16285280
1,6,22.1,Weight decreased,16285280
2,4,22.1,Basedow^s disease,16285280
3,6,22.1,Off label use,16285280
4,1,22.1,Haemoptysis,16285280
5,6,22.1,Weight increased,16285280
6,1,22.1,Hypothyroidism,16285280
0,5,22.0,Death,16285282
0,6,22.0,Neck pain,16285293
0,3,22.0,Headache,16285341
0,6,22.0,Skin cancer,16285346
1,6,22.0,Stomatitis,16285346
2,2,22.0,Palmar-plantar erythrodysaesthesia syndrome,16285346
3,6,22.0,Nausea,16285346
4,6,22.0,Second primary malignancy,16285346
0,2,22.0,Decreased appetite,16285389
1,2,22.0,Muscular weakness,16285389
2,1,22.0,Febrile neutropenia,16285389
3,1,22.0,Platelet count decreased,16285389
4,2,22.0,Petechiae,16285389
0,,22.0,Escherichia sepsis,16285393
0,2,22.0,Rash,16285416
0,1,22.0,Anaemia,16285422
1,1,22.0,Bicytopenia,16285422
0,1,22.0,Acute myocardial infarction,16285425
1,1,22.0,Electrocardiogram abnormal,16285425
0,6,22.0,Disease progression,16285477
1,6,22.0,Arthralgia,16285477
0,,22.0,Arthralgia,16285543
1,,22.0,Mobility decreased,16285543
2,,22.0,Nausea,16285543
0,2,22.1,Fatigue,16285644
1,2,22.1,Dysphagia,16285644
2,2,22.1,Encephalopathy,16285644
3,2,22.1,Amnestic disorder,16285644
4,2,22.1,Oesophageal infection,16285644
5,2,22.1,Neutropenia,16285644
6,2,22.1,Oesophageal candidiasis,16285644
7,2,22.1,Helicobacter test positive,16285644
8,2,22.1,Urethritis,16285644
9,2,22.1,Loss of consciousness,16285644
10,2,22.1,Haemoglobin decreased,16285644
11,2,22.1,Sepsis,16285644
12,6,22.1,Hypoglycaemia,16285644
13,2,22.1,Asthenia,16285644
14,2,22.1,Nephrolithiasis,16285644
15,2,22.1,Hyperglycaemia,16285644
0,2,22.0,Dyspnoea,16285658
1,2,22.0,Troponin I increased,16285658
2,2,22.0,Oedema peripheral,16285658
0,6,22.0,Headache,16285659
1,6,22.0,Dizziness,16285659
2,6,22.0,Brain neoplasm,16285659
3,6,22.0,Visual impairment,16285659
0,1,22.0,Pyrexia,16285705
1,1,22.0,Febrile neutropenia,16285705
2,6,22.0,Pneumonia,16285705
0,,22.0,Therapy cessation,16285731
1,,22.0,Post procedural infection,16285731
0,2,22.0,Neutropenia,16285794
1,2,22.0,Lymphopenia,16285794
0,,22.0,Death,16285830
0,2,22.0,Melaena,16285889
0,3,22.0,Stevens-Johnson syndrome,16285901
0,6,22.0,Acute kidney injury,16285914
1,3,22.0,Blood creatinine increased,16285914
2,3,22.0,Fatigue,16285914
3,3,22.0,Renal impairment,16285914
4,6,22.0,Dyspnoea exertional,16285914
5,6,22.0,Product dose omission,16285914
0,6,22.0,Condition aggravated,16285962
0,2,22.1,Drug intolerance,16285976
1,2,22.1,Cardiac failure congestive,16285976
0,3,22.0,Infusion site extravasation,16286132
1,6,22.0,Product use in unapproved indication,16286132
2,3,22.0,Abdominal pain upper,16286132
3,1,22.0,Infusion site extravasation,16286132
4,3,22.0,Fatigue,16286132
5,3,22.0,Device use issue,16286132
6,3,22.0,Nausea,16286132
7,3,22.0,Sinusitis,16286132
8,1,22.0,Infusion site swelling,16286132
9,6,22.0,No adverse event,16286132
0,6,22.0,Blindness,16286158
1,6,22.0,Deafness,16286158
2,6,22.0,Balance disorder,16286158
3,3,22.0,Prostatic specific antigen increased,16286158
4,6,22.0,Drug ineffective,16286158
0,1,22.0,Aspartate aminotransferase increased,16286168
0,6,22.0,Hypoacusis,16286221
0,6,22.0,Off label use,16286294
1,6,22.0,Visual impairment,16286294
2,6,22.0,Pain,16286294
3,6,22.0,Malaise,16286294
4,6,22.0,Somnolence,16286294
5,6,22.0,Product use in unapproved indication,16286294
6,6,22.0,Fatigue,16286294
7,6,22.0,Decreased appetite,16286294
0,6,22.0,Lung adenocarcinoma,16286319
1,6,22.0,Malignant neoplasm progression,16286319
2,6,22.0,Non-small cell lung cancer stage IV,16286319
0,,22.0,Flushing,16286391
1,,22.0,Drug hypersensitivity,16286391
2,,22.0,Feeling hot,16286391
0,,22.0,Palmar-plantar erythrodysaesthesia syndrome,16286406
1,,22.0,Skin discolouration,16286406
0,,22.0,Myositis,16286419
0,6,22.0,Radiotherapy,16286433
1,3,22.0,Genital pain,16286433
2,3,22.0,Haematochezia,16286433
3,3,22.0,Pain in extremity,16286433
0,6,22.0,Adverse drug reaction,16286441
1,6,22.0,Malignant neoplasm progression,16286441
0,,22.0,Seizure,16286462
0,,22.0,Discomfort,16286464
1,,22.0,Flushing,16286464
2,,22.0,Chest discomfort,16286464
3,,22.0,Infusion related reaction,16286464
4,,22.0,Dyspnoea,16286464
0,6,22.0,Bone marrow failure,16286477
1,6,22.0,Hepatic function abnormal,16286477
0,6,22.0,Disease progression,16286509
0,1,22.0,Malaise,16286532
0,,22.0,Flushing,16286534
1,,22.0,Infusion related reaction,16286534
2,,22.0,Feeling hot,16286534
0,6,22.0,Constipation,16286557
0,,22.0,Rehabilitation therapy,16286596
0,6,22.0,Blood count abnormal,16286605
1,3,22.0,Fatigue,16286605
2,3,22.0,Nausea,16286605
3,6,22.0,Product dose omission,16286605
4,3,22.0,Bone pain,16286605
5,3,22.0,Decreased appetite,16286605
6,6,22.0,Malaise,16286605
7,3,22.0,Vomiting,16286605
8,6,22.0,Asthenia,16286605
0,6,22.0,Carcinoembryonic antigen increased,16286650
1,6,22.0,Metastases to central nervous system,16286650
2,6,22.0,Drug resistance,16286650
0,1,22.0,Diarrhoea,16286663
1,1,22.0,Vomiting,16286663
0,,22.0,Therapy cessation,16286664
1,,22.0,Oophorectomy,16286664
0,5,22.0,Death,16286678
0,5,22.0,Death,16286692
1,3,22.0,Nausea,16286692
2,3,22.0,Fatigue,16286692
0,5,22.0,Death,16286702
0,2,22.1,Generalised oedema,16286738
1,6,22.1,Disease progression,16286738
0,1,22.0,Respiratory failure,16286750
0,3,22.0,Fatigue,16286759
1,1,22.0,Oral discomfort,16286759
2,1,22.0,Aphthous ulcer,16286759
3,5,22.0,Breast cancer,16286759
4,6,22.0,Fall,16286759
5,2,22.0,Somnolence,16286759
6,5,22.0,Malignant neoplasm progression,16286759
7,6,22.0,Haemoglobin decreased,16286759
0,6,22.0,Malignant neoplasm progression,16286816
1,6,22.0,Deafness,16286816
2,6,22.0,Schizophrenia,16286816
3,6,22.0,Cataract,16286816
4,6,22.0,Blindness,16286816
0,1,22.0,Carotidynia,16286862
0,6,22.0,Nausea,16286871
1,6,22.0,Death,16286871
2,6,22.0,Malignant neoplasm progression,16286871
3,6,22.0,Intentional product misuse,16286871
4,6,22.0,Fatigue,16286871
0,5,22.0,Death,16286880
1,6,22.0,Off label use,16286880
0,2,22.0,Haemorrhagic stroke,16286910
1,6,22.0,Pulmonary embolism,16286910
0,1,22.0,Pyrexia,16286915
1,1,22.0,Myalgia,16286915
2,6,22.0,Sepsis,16286915
3,1,22.0,Lethargy,16286915
4,1,22.0,Malaise,16286915
5,1,22.0,Oropharyngeal pain,16286915
6,6,22.0,Flushing,16286915
7,6,22.0,Pharyngitis,16286915
0,6,22.0,Malaise,16286946
0,6,22.0,Nausea,16286955
1,6,22.0,Swelling face,16286955
2,1,22.0,Neutropenia,16286955
3,6,22.0,Vomiting,16286955
4,6,22.0,Erythema,16286955
5,6,22.0,Dehydration,16286955
0,6,22.0,Pulmonary oedema,16286963
1,6,22.0,Fatigue,16286963
2,6,22.0,Sneezing,16286963
3,6,22.0,Cough,16286963
4,6,22.0,Middle insomnia,16286963
5,6,22.0,Stress,16286963
6,6,22.0,Dyspnoea,16286963
7,3,22.0,Full blood count decreased,16286963
8,6,22.0,Seasonal allergy,16286963
0,5,22.0,Off label use,16287017
1,5,22.0,Acute kidney injury,16287017
2,5,22.0,Anuria,16287017
3,5,22.0,Intentional product use issue,16287017
0,4,22.0,Wheezing,16287030
1,4,22.0,Dyspnoea,16287030
2,4,22.0,Chest discomfort,16287030
0,5,22.0,Haemorrhagic arteriovenous malformation,16287036
1,6,22.0,Headache,16287036
0,5,22.0,Death,16287041
0,1,22.0,Candida infection,16287047
1,6,22.0,Hypersomnia,16287047
2,6,22.0,Neoplasm progression,16287047
3,6,22.0,Diplopia,16287047
4,6,22.0,Arteriovenous malformation,16287047
5,1,22.0,Pneumonia,16287047
0,1,22.0,Gastric perforation,16287054
0,6,22.0,Osteonecrosis of jaw,16287059
1,6,22.0,Infection,16287059
0,1,22.0,Decreased appetite,16287066
0,1,22.0,Epistaxis,16287069
1,3,22.0,Pyrexia,16287069
2,3,22.0,Back pain,16287069
3,3,22.0,Decreased appetite,16287069
4,3,22.0,Abdominal pain upper,16287069
0,2,22.0,Renal cancer,16287080
1,3,22.0,Off label use,16287080
2,1,22.0,Feeling abnormal,16287080
3,1,22.0,Restlessness,16287080
4,3,22.0,Wrong technique in product usage process,16287080
5,1,22.0,Muscle twitching,16287080
6,2,22.0,Benign prostatic hyperplasia,16287080
7,6,22.0,Overweight,16287080
8,2,22.0,Urinary retention,16287080
9,1,22.0,Drug withdrawal syndrome,16287080
10,6,22.0,Neuropathy peripheral,16287080
0,3,22.0,Alopecia,16287087
1,6,22.0,Amnesia,16287087
2,6,22.0,Arthralgia,16287087
3,6,22.0,Diabetes mellitus,16287087
4,6,22.0,Neoplasm progression,16287087
5,3,22.0,Bone pain,16287087
0,3,22.0,Neuropathy peripheral,16287113
0,1,22.0,Tachycardia,16287123
1,6,22.0,Hypersensitivity,16287123
2,6,22.0,Product substitution issue,16287123
3,1,22.0,Feeling hot,16287123
4,1,22.0,Hyperhidrosis,16287123
0,1,22.0,Chest discomfort,16287137
1,1,22.0,Feeling hot,16287137
2,1,22.0,Pruritus,16287137
3,1,22.0,Erythema,16287137
0,6,22.0,Sepsis,16287176
1,6,22.0,Decubitus ulcer,16287176
2,6,22.0,Product dose omission,16287176
3,5,22.0,Death,16287176
0,6,22.0,Red blood cell count decreased,16287206
1,6,22.0,White blood cell count decreased,16287206
0,1,22.0,Cardiac tamponade,16287209
1,6,22.0,Dyspnoea,16287209
2,2,22.0,Malignant neoplasm progression,16287209
0,6,22.0,Drug ineffective,16287244
0,6,22.0,Osteonecrosis of jaw,16287252
0,6,22.0,Product use in unapproved indication,16287366
1,6,22.0,Adverse event,16287366
0,6,22.1,Liver injury,16287454
1,6,22.1,Nephrotic syndrome,16287454
2,2,22.1,Albuminuria,16287454
3,6,22.1,Drug ineffective,16287454
4,6,22.1,Bone marrow toxicity,16287454
5,6,22.1,Condition aggravated,16287454
6,6,22.1,Therapeutic response decreased,16287454
7,6,22.1,Disease progression,16287454
0,5,22.0,Death,16287482
0,1,22.0,Pneumonia,16287490
1,3,22.0,Memory impairment,16287490
0,5,22.0,Respiratory failure,16287497
0,1,22.0,Disease recurrence,16287560
1,1,22.0,Memory impairment,16287560
2,1,22.0,Amnesia,16287560
3,1,22.0,Pneumonia aspiration,16287560
0,6,22.0,Malignant neoplasm progression,16287638
1,6,22.0,Drug resistance,16287638
0,6,22.0,Thrombosis,16287715
0,1,22.0,Leukopenia,16287718
1,1,22.0,Myelodysplastic syndrome,16287718
2,6,22.0,Mucosal haemorrhage,16287718
3,1,22.0,Thrombocytopenia,16287718
4,6,22.0,Neutropenia,16287718
0,1,22.0,Alopecia,16287726
1,6,22.0,Depression,16287726
2,6,22.0,Fatigue,16287726
3,1,22.0,Platelet count decreased,16287726
0,1,22.0,Cardiomyopathy,16287745
1,6,22.0,Hypotension,16287745
2,6,22.0,Sinus tachycardia,16287745
0,6,22.0,Atrial flutter,16287751
1,2,22.0,Thyroid dermatopathy,16287751
2,2,22.0,Hyperthyroidism,16287751
3,6,22.0,Anaemia,16287751
4,6,22.0,Tachycardia,16287751
0,1,22.1,Ventricular hypokinesia,16287802
0,5,22.0,Death,16287806
0,1,22.1,Leukopenia,16287871
1,1,22.1,Thrombocytopenia,16287871
2,3,22.1,Pleural effusion,16287871
3,1,22.1,Rotavirus infection,16287871
4,1,22.1,Diarrhoea,16287871
5,1,22.1,Leukopenia,16287871
6,3,22.1,Dyspnoea,16287871
7,3,22.1,General physical health deterioration,16287871
8,3,22.1,Lymphoedema,16287871
9,1,22.1,Lymphopenia,16287871
10,1,22.1,Neutropenia,16287871
11,1,22.1,Diarrhoea,16287871
12,1,22.1,Pneumothorax,16287871
13,3,22.1,Vitamin D deficiency,16287871
14,1,22.1,Thrombocytopenia,16287871
15,3,22.1,Nausea,16287871
16,3,22.1,Carbohydrate antigen 15-3 increased,16287871
17,1,22.1,Neutropenia,16287871
18,1,22.1,Thrombocytopenia,16287871
0,2,22.0,Retroperitoneal cancer,16287872
1,1,22.0,Myelodysplastic syndrome,16287872
2,1,22.0,Thrombocytosis,16287872
3,2,22.0,Malignant neoplasm progression,16287872
4,1,22.0,Anaemia,16287872
5,1,22.0,Second primary malignancy,16287872
6,1,22.0,Diarrhoea,16287872
7,2,22.0,Metastases to liver,16287872
0,6,22.0,Cataract,16287912
1,3,22.0,Retinal haemorrhage,16287912
2,6,22.0,Eye haemorrhage,16287912
3,6,22.0,Choroidal neovascularisation,16287912
0,3,22.0,Mass,16287933
1,6,22.0,Breast mass,16287933
2,3,22.0,Spinal pain,16287933
0,1,22.1,Pyrexia,16287950
1,1,22.1,Device related infection,16287950
2,1,22.1,Chills,16287950
3,1,22.1,Vomiting,16287950
4,1,22.1,Lip infection,16287950
5,1,22.1,Lip infection,16287950
6,1,22.1,Bronchitis,16287950
0,3,22.0,Pseudocirrhosis,16287960
0,2,22.0,Colitis,16287989
1,6,22.0,Dehydration,16287989
2,6,22.0,Malaise,16287989
3,2,22.0,Diarrhoea,16287989
4,6,22.0,Vomiting,16287989
5,2,22.0,Gait disturbance,16287989
6,6,22.0,Pain,16287989
7,2,22.0,Gastroenteritis,16287989
8,2,22.0,Nausea,16287989
0,6,22.0,Hypoglycaemia,16288011
0,5,22.0,Death,16288014
0,3,22.0,Adverse event,16288028
1,3,22.0,Treatment failure,16288028
2,6,22.0,Product use in unapproved indication,16288028
0,6,22.0,Malignant neoplasm progression,16288077
1,6,22.0,Non-small cell lung cancer stage IV,16288077
2,6,22.0,Lung adenocarcinoma,16288077
0,3,22.0,Asthenia,16288092
0,6,22.0,Colitis,16288100
1,6,22.0,Sepsis,16288100
0,6,22.0,Anaemia,16288232
0,3,22.0,Colitis ulcerative,16288233
1,1,22.0,Sepsis,16288233
0,6,22.0,Febrile neutropenia,16288238
1,6,22.0,Neuropathy peripheral,16288238
2,6,22.0,Pulmonary embolism,16288238
3,6,22.0,Pain,16288238
4,6,22.0,Nausea,16288238
5,6,22.0,Anaphylactic reaction,16288238
6,2,22.0,Peripheral swelling,16288238
0,6,22.0,Product administered at inappropriate site,16288254
1,6,22.0,General physical health deterioration,16288254
2,6,22.0,Injection site erythema,16288254
3,1,22.0,Injection site pain,16288254
4,6,22.0,Fatigue,16288254
0,1,22.1,Embolism,16288261
0,1,22.0,Bone marrow failure,16288276
0,2,22.0,Dyspnoea,16288289
1,2,22.0,Troponin I increased,16288289
2,2,22.0,Oedema peripheral,16288289
0,1,22.0,Rash,16288407
1,1,22.0,Pyrexia,16288407
2,6,22.0,Off label use,16288407
0,6,22.0,Rash,16288418
1,6,22.0,Gait disturbance,16288418
2,6,22.0,Diarrhoea,16288418
3,6,22.0,Vomiting,16288418
4,6,22.0,Acute kidney injury,16288418
5,6,22.0,Hypophosphataemia,16288418
6,6,22.0,Dizziness,16288418
7,6,22.0,Fatigue,16288418
8,6,22.0,Dehydration,16288418
9,6,22.0,Hypokalaemia,16288418
10,6,22.0,Myalgia,16288418
11,6,22.0,Febrile neutropenia,16288418
12,6,22.0,Decreased appetite,16288418
13,6,22.0,Blood bilirubin increased,16288418
14,6,22.0,Neutropenia,16288418
15,6,22.0,Nausea,16288418
0,3,22.0,Malignant neoplasm progression,16288457
1,1,22.0,Pruritus,16288457
2,1,22.0,Liver function test increased,16288457
0,2,22.0,Hypotension,16288485
1,2,22.0,Hyperhidrosis,16288485
2,2,22.0,Motor dysfunction,16288485
3,2,22.0,Bradycardia,16288485
0,3,22.0,Hot flush,16288523
1,3,22.0,Memory impairment,16288523
0,6,22.0,Haemorrhage,16288549
0,6,22.0,Perforated ulcer,16288569
1,5,22.0,Malignant neoplasm progression,16288569
0,3,22.0,Colon cancer stage IV,16288606
0,3,22.0,Osteonecrosis of jaw,16288632
0,6,22.0,White blood cell count decreased,16288650
1,6,22.0,Alopecia,16288650
2,6,22.0,Neoplasm progression,16288650
3,1,22.0,Supraventricular tachycardia,16288650
4,3,22.0,Constipation,16288650
0,6,22.0,Abdominal pain,16288664
1,6,22.0,Xerophthalmia,16288664
2,6,22.0,Diarrhoea,16288664
0,6,22.0,Malignant neoplasm progression,16288667
0,6,22.0,Malignant neoplasm progression,16288689
0,6,22.0,Malignant neoplasm progression,16288693
0,1,22.0,Erythema multiforme,16288695
0,6,22.0,Toxicity to various agents,16288701
0,6,22.0,Malignant neoplasm progression,16288723
1,6,22.0,Cytogenetic analysis abnormal,16288723
2,6,22.0,Breast cancer metastatic,16288723
0,1,22.0,Cancer pain,16288748
1,1,22.0,Neutrophil count decreased,16288748
2,1,22.0,Decreased appetite,16288748
0,6,22.0,Malignant neoplasm progression,16288758
0,1,22.0,Hyponatraemic seizure,16288774
1,1,22.0,Hyponatraemia,16288774
2,1,22.0,Blood osmolarity decreased,16288774
3,1,22.0,Postictal state,16288774
0,6,22.0,Leukopenia,16288775
1,6,22.0,Bone marrow failure,16288775
0,6,22.0,Mucosal inflammation,16288783
1,6,22.0,Lacrimation increased,16288783
2,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16288783
0,1,22.0,Subdural haematoma,16288840
1,3,22.0,Thrombocytopenia,16288840
0,1,22.0,Nausea,16288856
1,6,22.0,Product use issue,16288856
2,6,22.0,Product prescribing error,16288856
3,6,22.0,Product use in unapproved indication,16288856
0,1,22.0,Pericardial effusion,16288995
1,6,22.0,Cardiac failure,16288995
0,6,22.0,Adverse event,16288996
1,6,22.0,Packed red blood cell transfusion,16288996
2,6,22.0,Malignant pleural effusion,16288996
3,6,22.0,Chest tube insertion,16288996
0,5,22.0,Prostate cancer,16289026
0,6,22.0,Sepsis,16289042
1,5,22.0,Malignant neoplasm progression,16289042
2,,22.0,Generalised oedema,16289042
0,6,22.0,Chronic obstructive pulmonary disease,16289043
0,6,22.0,Platelet count decreased,16289044
1,6,22.0,Fatigue,16289044
2,6,22.0,Carpal tunnel syndrome,16289044
3,6,22.0,Muscular weakness,16289044
4,6,22.0,Myalgia,16289044
5,6,22.0,Red blood cell count decreased,16289044
6,6,22.0,Neutrophil count abnormal,16289044
0,1,22.0,Anaemia,16289050
1,2,22.0,Gastrointestinal haemorrhage,16289050
0,5,22.0,Colitis,16289056
0,6,22.0,Drug ineffective,16289185
0,5,22.0,Malignant neoplasm progression,16289218
0,2,22.0,Hepatotoxicity,16289225
1,2,22.0,Proteinuria,16289225
2,2,22.0,Haematuria,16289225
0,1,22.0,Tachyarrhythmia,16289230
0,6,22.0,Atrial flutter,16289232
0,6,22.0,Neuropathy peripheral,16289233
1,6,22.0,Bone marrow failure,16289233
0,,22.0,Recurrent cancer,16289429
1,,22.0,Metastasis,16289429
0,3,22.0,Diarrhoea,16289497
1,3,22.0,Asthenia,16289497
2,3,22.0,Decreased appetite,16289497
3,3,22.0,Rash,16289497
0,,22.0,Haemoglobin decreased,16289541
1,,22.0,Peripheral swelling,16289541
0,1,22.0,Headache,16289543
1,1,22.0,Atrial fibrillation,16289543
2,1,22.0,Hyperhidrosis,16289543
0,1,22.0,Respiratory failure,16289545
1,1,22.0,Bronchospasm,16289545
0,2,22.0,Cardiorenal syndrome,16289604
1,2,22.0,Cor pulmonale acute,16289604
2,2,22.0,Pulmonary embolism,16289604
0,6,22.0,Alanine aminotransferase increased,16289616
1,6,22.0,Hypersensitivity,16289616
2,6,22.0,Neutropenia,16289616
0,6,22.0,Metastases to spine,16289639
1,6,22.0,Lung disorder,16289639
2,6,22.0,Metastases to bone,16289639
3,6,22.0,Metastases to liver,16289639
4,6,22.0,Lung disorder,16289639
5,6,22.0,Metastases to central nervous system,16289639
6,6,22.0,Metastases to pelvis,16289639
7,6,22.0,Small cell lung cancer,16289639
8,6,22.0,Metastases to liver,16289639
9,6,22.0,Metastases to adrenals,16289639
0,2,22.0,Mental status changes,16289662
1,6,22.0,Thrombocytopenia,16289662
2,6,22.0,Dyspnoea,16289662
3,6,22.0,Metastases to meninges,16289662
4,6,22.0,Lymphocyte count decreased,16289662
5,5,22.0,Death,16289662
6,6,22.0,Renal injury,16289662
7,6,22.0,Asthenia,16289662
8,6,22.0,Dehydration,16289662
9,6,22.0,Aspartate aminotransferase increased,16289662
10,6,22.0,Sepsis,16289662
11,6,22.0,Lactic acidosis,16289662
0,,22.0,Pyrexia,16289704
0,,22.0,Renal failure,16289711
0,3,22.0,Off label use,16289723
1,6,22.0,Prescribed overdose,16289723
2,6,22.0,Hypoglycaemia,16289723
0,6,22.1,Lung disorder,16289751
1,6,22.1,Drug ineffective,16289751
2,1,22.1,Metastases to liver,16289751
3,6,22.1,Diarrhoea,16289751
4,6,22.1,Bone marrow toxicity,16289751
5,6,22.1,Rash,16289751
0,1,22.0,Hypoglycaemia,16289758
1,3,22.0,Drug-induced liver injury,16289758
0,3,22.0,Diarrhoea,16289780
1,1,22.0,Abdominal pain upper,16289780
2,3,22.0,Trace element deficiency,16289780
3,3,22.0,Thrombosis,16289780
4,3,22.0,Hypotension,16289780
5,3,22.0,Ammonia increased,16289780
6,1,22.0,Confusional state,16289780
7,1,22.0,Headache,16289780
0,1,22.0,Renal failure,16289800
0,1,22.0,Rectal abscess,16289812
1,1,22.0,Pelvic abscess,16289812
2,1,22.0,Faecaloma,16289812
3,1,22.0,Oedema peripheral,16289812
4,1,22.0,Renal failure,16289812
5,1,22.0,Diarrhoea,16289812
6,1,22.0,Subileus,16289812
7,1,22.0,Rectal stenosis,16289812
0,3,22.0,Malignant neoplasm progression,16289818
1,3,22.0,Hyperhidrosis,16289818
2,3,22.0,Postoperative wound complication,16289818
3,3,22.0,Toxicity to various agents,16289818
4,3,22.0,Rheumatoid arthritis,16289818
5,3,22.0,Breast cancer recurrent,16289818
0,1,22.0,Blood pressure increased,16289823
1,1,22.0,Bronchospasm,16289823
2,1,22.0,Laryngospasm,16289823
3,1,22.0,Erythema,16289823
0,2,22.0,Breast cancer,16289825
1,2,22.0,Metastases to central nervous system,16289825
2,2,22.0,Platelet count decreased,16289825
3,2,22.0,Immunosuppression,16289825
4,2,22.0,Protein total increased,16289825
5,2,22.0,Headache,16289825
6,2,22.0,Meningoencephalitis herpetic,16289825
7,2,22.0,Metastases to liver,16289825
8,2,22.0,Asthenia,16289825
9,2,22.0,Malignant neoplasm progression,16289825
10,2,22.0,Metastases to eye,16289825
0,6,22.0,Syringe issue,16289834
1,6,22.0,Intercepted product preparation error,16289834
2,5,22.0,Cerebrovascular accident,16289834
3,6,22.0,Asthenia,16289834
0,6,22.0,Ill-defined disorder,16289845
1,5,22.0,Death,16289845
0,2,22.0,Urinary retention,16289859
1,2,22.0,Prostatic specific antigen increased,16289859
2,2,22.0,Pain,16289859
3,2,22.0,Thrombosis,16289859
4,2,22.0,Dyspnoea,16289859
5,2,22.0,Abdominal distension,16289859
6,2,22.0,Nephrolithiasis,16289859
7,2,22.0,Haemorrhage urinary tract,16289859
8,2,22.0,Testicular pain,16289859
0,,22.0,Fatigue,16289862
1,,22.0,Skin reaction,16289862
2,,22.0,Hypothyroidism,16289862
0,,22.0,Palmar-plantar erythrodysaesthesia syndrome,16289879
0,6,22.0,Headache,16289913
1,6,22.0,Weight increased,16289913
2,6,22.0,Wheezing,16289913
3,6,22.0,Pyrexia,16289913
4,6,22.0,Fatigue,16289913
5,6,22.0,Cough,16289913
6,1,22.0,Diarrhoea,16289913
7,6,22.0,Spinal compression fracture,16289913
8,6,22.0,Chest pain,16289913
9,1,22.0,Vomiting,16289913
10,6,22.0,Incorrect route of product administration,16289913
11,6,22.0,Pulmonary embolism,16289913
12,6,22.0,Dyspnoea,16289913
13,3,22.0,Abdominal pain lower,16289913
14,2,22.0,Pneumonia,16289913
15,6,22.0,Tremor,16289913
16,6,22.0,Back pain,16289913
0,1,22.0,Sinusitis,16289927
1,2,22.0,Palatal disorder,16289927
2,1,22.0,Nasal septum deviation,16289927
0,6,22.0,Malignant neoplasm progression,16289935
1,6,22.0,Gastrointestinal toxicity,16289935
2,6,22.0,Cardiac failure congestive,16289935
3,6,22.0,Ejection fraction decreased,16289935
4,6,22.0,Breast cancer metastatic,16289935
5,6,22.0,Thrombosis,16289935
6,6,22.0,Sepsis,16289935
7,6,22.0,Disease progression,16289935
0,6,22.0,Malignant neoplasm progression,16289945
1,6,22.0,Breast cancer metastatic,16289945
2,6,22.0,Inappropriate schedule of product administration,16289945
3,5,22.0,Death,16289945
0,5,22.0,Death,16289955
0,6,22.0,Drug hypersensitivity,16289970
0,6,22.0,Ascites,16289978
0,1,22.0,Hypothyroidism,16289979
1,1,22.0,Hyperthyroidism,16289979
0,1,22.1,Platelet count decreased,16289985
1,1,22.1,Neutrophil count decreased,16289985
2,2,22.1,Gastrointestinal haemorrhage,16289985
0,,22.0,Diplopia,16290023
1,,22.0,Fatigue,16290023
2,,22.0,Cyanosis,16290023
3,,22.0,Hypersensitivity,16290023
0,6,22.0,Diarrhoea,16290031
1,6,22.0,Hepatitis,16290031
2,6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16290031
0,3,22.0,Nephrotic syndrome,16290032
0,,22.0,Death,16290034
0,6,22.1,Proteinuria,16290074
1,6,22.1,Diarrhoea,16290074
2,6,22.1,Leukopenia,16290074
3,6,22.1,Febrile neutropenia,16290074
4,6,22.1,Vomiting,16290074
5,6,22.1,Neutropenia,16290074
6,6,22.1,Gastrointestinal perforation,16290074
7,6,22.1,Thrombocytopenia,16290074
8,6,22.1,Anaemia,16290074
9,6,22.1,Nausea,16290074
10,6,22.1,Fatigue,16290074
11,6,22.1,Hypertension,16290074
12,6,22.1,Decreased appetite,16290074
0,6,22.0,Gastrointestinal motility disorder,16290109
1,3,22.0,Nail infection,16290109
2,3,22.0,Nail disorder,16290109
3,3,22.0,Peripheral swelling,16290109
4,3,22.0,Diarrhoea,16290109
5,6,22.0,Tongue erythema,16290109
6,3,22.0,Rash,16290109
7,3,22.0,Pain in extremity,16290109
8,3,22.0,Fungal infection,16290109
9,3,22.0,Skin disorder,16290109
10,6,22.0,Decreased appetite,16290109
11,3,22.0,Malignant neoplasm progression,16290109
12,3,22.0,Onychomadesis,16290109
13,3,22.0,Localised infection,16290109
14,3,22.0,Dysgeusia,16290109
15,3,22.0,Dry mouth,16290109
16,3,22.0,Eye pain,16290109
17,3,22.0,Skin exfoliation,16290109
18,6,22.0,Diarrhoea,16290109
19,3,22.0,Glossodynia,16290109
20,6,22.0,Fatigue,16290109
21,6,22.0,Paronychia,16290109
22,3,22.0,Oral pain,16290109
23,3,22.0,Traumatic haematoma,16290109
24,1,22.0,Dysgeusia,16290109
25,3,22.0,Chapped lips,16290109
0,6,22.0,Electrocardiogram ST segment elevation,16290127
0,1,22.0,Arteriospasm coronary,16290151
0,2,22.0,Cardiogenic shock,16290190
1,2,22.0,Septic shock,16290190
2,6,22.0,Dyspnoea,16290190
3,6,22.0,Angina pectoris,16290190
0,,22.0,Disease progression,16290194
1,,22.0,Uterine dilation and curettage,16290194
2,,22.0,Menstrual disorder,16290194
3,,22.0,Uterine leiomyoma,16290194
0,6,22.0,Polyneuropathy,16290223
1,6,22.0,Diarrhoea,16290223
2,6,22.0,Febrile neutropenia,16290223
0,,22.0,Fatigue,16290227
1,,22.0,Haemoglobin decreased,16290227
0,3,22.0,Acute kidney injury,16290228
0,1,22.0,Muscle abscess,16290349
0,3,22.0,Off label use,16290375
1,3,22.0,Product use in unapproved indication,16290375
2,3,22.0,Osteoarthritis,16290375
0,6,22.0,Dizziness,16290383
1,6,22.0,Inappropriate schedule of product administration,16290383
2,2,22.0,Back pain,16290383
3,6,22.0,Fall,16290383
4,6,22.0,Neck pain,16290383
5,6,22.0,Decreased appetite,16290383
6,6,22.0,Hyperhidrosis,16290383
7,2,22.0,Fatigue,16290383
8,6,22.0,Hot flush,16290383
9,6,22.0,Drug interaction,16290383
0,5,22.0,Acute coronary syndrome,16290384
0,,22.0,Death,16290388
0,,22.0,Death,16290395
0,2,22.0,Cardiac failure,16290438
1,2,22.0,Cardiomyopathy,16290438
2,2,22.0,Left ventricular dysfunction,16290438
0,6,22.0,Thrombocytopenia,16290470
0,5,22.0,Febrile neutropenia,16290481
1,5,22.0,Pneumonia,16290481
2,5,22.0,Sepsis,16290481
0,6,22.0,Ascites,16290507
1,2,22.0,Pyrexia,16290507
2,2,22.0,Rash,16290507
3,2,22.0,Hepatitis,16290507
4,2,22.0,C-reactive protein increased,16290507
5,1,22.0,Colitis,16290507
6,2,22.0,Stomatitis,16290507
7,2,22.0,Infusion related reaction,16290507
8,6,22.0,Pancreatitis,16290507
9,6,22.0,Generalised oedema,16290507
10,6,22.0,Pancytopenia,16290507
11,2,22.0,Toxic skin eruption,16290507
12,6,22.0,Pleural effusion,16290507
13,2,22.0,Oedema peripheral,16290507
14,1,22.0,Liver disorder,16290507
0,4,22.0,Osteonecrosis,16290554
0,2,22.0,Haematuria,16290582
1,2,22.0,Vomiting,16290582
0,1,22.1,Seizure,16290644
1,1,22.1,Sinus bradycardia,16290644
2,1,22.1,Hypertension,16290644
0,6,22.0,Dyspepsia,16290661
1,6,22.0,Cancer pain,16290661
2,6,22.0,Hypertension,16290661
3,6,22.0,Contusion,16290661
0,3,22.0,Neuropathy peripheral,16290694
1,3,22.0,Burning sensation,16290694
2,6,22.0,Fatigue,16290694
3,3,22.0,Pain,16290694
4,3,22.0,Tendonitis,16290694
5,6,22.0,Gait inability,16290694
0,1,22.0,Lower gastrointestinal haemorrhage,16290707
0,6,22.0,White blood cell count decreased,16290708
1,6,22.0,Feeling abnormal,16290708
2,6,22.0,Fall,16290708
3,6,22.0,Hip fracture,16290708
4,6,22.0,Fracture,16290708
5,6,22.0,Neoplasm progression,16290708
0,6,22.1,White blood cell count decreased,16290760
1,6,22.1,Neutropenia,16290760
0,6,22.1,Nail disorder,16290769
1,6,22.1,Peripheral swelling,16290769
2,6,22.1,Onychalgia,16290769
0,1,22.0,Cytopenia,16290791
0,6,22.1,Intentional product misuse,16290796
1,1,22.1,Insomnia,16290796
0,6,22.0,Malignant neoplasm progression,16290842
1,2,22.0,Pneumonia aspiration,16290842
0,1,22.0,Infusion related reaction,16290875
0,3,22.0,Fatigue,16290898
1,2,22.0,Bone marrow failure,16290898
2,6,22.0,Hypersomnia,16290898
3,6,22.0,Decreased appetite,16290898
4,2,22.0,Blood bilirubin increased,16290898
0,5,22.0,Pancytopenia,16290905
1,5,22.0,Death,16290905
0,5,22.0,Pericardial haemorrhage,16290935
1,6,22.0,Fatigue,16290935
2,5,22.0,Cardiac arrest,16290935
0,1,22.0,Craniocerebral injury,16290961
0,5,22.0,Metastases to liver,16290967
0,5,22.0,Death,16290988
0,1,22.0,Pruritus,16290989
1,1,22.0,Dermatitis exfoliative generalised,16290989
0,6,22.1,Stoma site inflammation,16291004
1,6,22.1,Diverticulum intestinal,16291004
2,6,22.1,Gastrointestinal disorder,16291004
3,6,22.1,Blood disorder,16291004
4,6,22.1,Proctitis,16291004
5,6,22.1,Excessive granulation tissue,16291004
6,6,22.1,Cholecystitis chronic,16291004
7,6,22.1,Neuropathy peripheral,16291004
8,6,22.1,Rectal polyp,16291004
9,6,22.1,Gallbladder cholesterolosis,16291004
0,6,22.0,Pain,16291008
1,6,22.0,Cough,16291008
0,6,22.0,Chromaturia,16291017
1,6,22.0,Haemorrhage,16291017
2,6,22.0,Bowel movement irregularity,16291017
3,6,22.0,Dysarthria,16291017
4,6,22.0,Coordination abnormal,16291017
5,6,22.0,Flatulence,16291017
6,5,22.0,Death,16291017
7,6,22.0,Abdominal pain upper,16291017
8,6,22.0,Dehydration,16291017
9,6,22.0,Asthenia,16291017
10,1,22.0,Nasopharyngitis,16291017
0,6,22.0,Neoplasm progression,16291040
1,6,22.0,Condition aggravated,16291040
0,1,22.0,Chills,16291045
1,1,22.0,Diarrhoea,16291045
2,1,22.0,Pruritus,16291045
3,1,22.0,Erythema,16291045
4,1,22.0,Hypersensitivity,16291045
5,3,22.0,Vomiting,16291045
0,6,22.0,Visual impairment,16291049
0,6,22.0,Disease progression,16291069
1,6,22.0,Malignant pleural effusion,16291069
2,1,22.0,Acute kidney injury,16291069
3,6,22.0,Dyspnoea,16291069
0,6,22.0,White blood cell count decreased,16291101
1,6,22.0,Haemoglobin decreased,16291101
2,6,22.0,Somnolence,16291101
0,2,22.0,Bone pain,16291117
1,2,22.0,Full blood count decreased,16291117
2,2,22.0,Fatigue,16291117
3,6,22.0,Neoplasm progression,16291117
4,2,22.0,Arthralgia,16291117
0,6,22.0,Product use in unapproved indication,16291133
1,6,22.0,Off label use,16291133
2,6,22.0,Product use issue,16291133
3,3,22.0,Malaise,16291133
0,1,22.0,Pyrexia,16291176
1,1,22.0,Dehydration,16291176
2,1,22.0,Klebsiella sepsis,16291176
3,3,22.0,Abdominal pain upper,16291176
4,3,22.0,Fatigue,16291176
5,3,22.0,Gastrointestinal haemorrhage,16291176
6,2,22.0,Anaemia,16291176
0,5,22.1,Multiple organ dysfunction syndrome,16291182
1,6,22.1,Diarrhoea,16291182
2,1,22.1,Thrombocytopenia,16291182
3,5,22.1,Cardiogenic shock,16291182
4,6,22.1,Toxicity to various agents,16291182
5,6,22.1,Epilepsy,16291182
6,6,22.1,Mucosal inflammation,16291182
7,1,22.1,Febrile neutropenia,16291182
8,5,22.1,Septic shock,16291182
9,5,22.1,Atrial fibrillation,16291182
10,5,22.1,Cardiac failure,16291182
11,6,22.1,Respiratory tract infection,16291182
12,5,22.1,Respiratory failure,16291182
13,5,22.1,Pancytopenia,16291182
0,6,22.0,Hyperglycaemia,16291209
1,6,22.0,Diabetic ketoacidosis,16291209
0,6,22.0,Arthralgia,16291224
1,6,22.0,Pain in extremity,16291224
2,3,22.0,Hot flush,16291224
3,3,22.0,Psoriatic arthropathy,16291224
4,1,22.0,Deep vein thrombosis,16291224
0,1,22.0,Neutropenia,16291241
1,6,22.0,Disease progression,16291241
2,5,22.0,Pneumonia,16291241
3,2,22.0,Anaemia,16291241
0,5,22.0,Death,16291244
0,6,22.0,Skin lesion,16291308
1,6,22.0,Inappropriate schedule of product administration,16291308
2,6,22.0,Malignant neoplasm progression,16291308
3,6,22.0,Breast cancer stage III,16291308
4,6,22.0,Dermatitis,16291308
5,6,22.0,Therapeutic response decreased,16291308
6,6,22.0,Metastases to skin,16291308
0,6,22.0,Cytomegalovirus colitis,16291333
1,5,22.0,Respiratory failure,16291333
2,5,22.0,Aspergillus infection,16291333
3,6,22.0,Cytomegalovirus infection,16291333
0,2,22.0,Febrile neutropenia,16291389
1,2,22.0,Sepsis,16291389
0,5,22.0,Tracheo-oesophageal fistula,16291393
1,5,22.0,Respiratory tract haemorrhage,16291393
0,3,22.0,Hepatic enzyme increased,16291474
0,6,22.0,Mental disorder,16291487
1,2,22.0,Pneumonia aspiration,16291487
2,2,22.0,Leukopenia,16291487
3,2,22.0,Cutaneous symptom,16291487
0,1,22.0,Hypoxia,16291539
1,1,22.0,Chills,16291539
0,3,22.0,Hot flush,16291544
1,3,22.0,Memory impairment,16291544
0,6,22.0,Type I hypersensitivity,16291554
0,6,22.0,Type I hypersensitivity,16291556
0,3,22.0,Ejection fraction decreased,16291615
0,3,22.0,Bedridden,16291624
1,5,22.0,Death,16291624
0,1,22.0,Hypersensitivity,16291632
1,1,22.0,Feeling hot,16291632
2,1,22.0,Chest pain,16291632
0,6,22.0,Pneumonitis,16291651
1,6,22.0,Malignant neoplasm progression,16291651
0,3,22.0,Neutropenia,16291667
1,6,22.0,Platelet count decreased,16291667
2,6,22.0,Haemoglobin decreased,16291667
3,3,22.0,Leukopenia,16291667
0,6,22.0,Product dose omission,16291700
1,6,22.0,Product availability issue,16291700
0,6,22.0,Cardiomyopathy,16291742
0,3,22.0,Pneumocystis jirovecii pneumonia,16291791
0,6,22.0,Lung infection,16291792
1,6,22.0,Chronic obstructive pulmonary disease,16291792
0,5,22.0,General physical health deterioration,16291805
0,3,22.0,Neuropathy peripheral,16291863
0,6,22.0,Off label use,16291874
1,3,22.0,Pulmonary embolism,16291874
0,6,22.0,Blood test abnormal,16291878
0,5,22.0,Neoplasm progression,16291949
0,5,22.0,Death,16292139
0,2,22.0,Bone marrow failure,16292274
0,1,22.0,Infection,16292317
0,1,22.0,Hepatic failure,16292386
0,6,22.0,Malaise,16292437
1,5,22.0,Sepsis,16292437
0,6,22.0,Colorectal cancer metastatic,16292439
1,6,22.0,Skin reaction,16292439
0,6,22.0,Thyroiditis,16292440
1,6,22.0,Anaemia,16292440
0,6,22.0,Fatigue,16292441
1,6,22.0,Hypertension,16292441
2,6,22.0,Thrombocytopenia,16292441
3,6,22.0,Diarrhoea,16292441
0,5,22.0,Metastases to neck,16292673
0,2,22.0,Hypomagnesaemia,16292705
1,2,22.0,Hypophosphataemia,16292705
2,1,22.0,Diarrhoea,16292705
3,2,22.0,Hypokalaemia,16292705
0,1,22.0,Metastases to lung,16293569
1,1,22.0,Haematotoxicity,16293569
0,6,22.0,Febrile neutropenia,16293650
1,6,22.0,Urinary tract infection bacterial,16293650
2,1,22.0,Septic shock,16293650
3,6,22.0,Cancer pain,16293650
4,6,22.0,Vomiting,16293650
0,1,22.0,Dyspnoea,16293654
1,1,22.0,Hyperthermia,16293654
2,1,22.0,Oxygen saturation decreased,16293654
0,6,22.0,Hypophysitis,16293680
0,6,22.0,Blood pressure decreased,16293704
1,2,22.0,Scoliosis,16293704
2,2,22.0,Pain,16293704
3,2,22.0,Intestinal obstruction,16293704
4,6,22.0,Abdominal pain,16293704
5,6,22.0,Malaise,16293704
6,6,22.0,Swelling,16293704
7,2,22.0,Hypertension,16293704
8,6,22.0,Dizziness,16293704
9,2,22.0,Liver disorder,16293704
0,5,22.0,Neoplasm progression,16293707
1,6,22.0,Vulvovaginal dryness,16293707
0,6,22.0,Haemorrhoids,16293776
1,3,22.0,Back pain,16293776
2,3,22.0,Contusion,16293776
3,3,22.0,Pulmonary oedema,16293776
4,6,22.0,White blood cell count abnormal,16293776
5,3,22.0,Carbohydrate antigen 125 increased,16293776
6,3,22.0,Nephrolithiasis,16293776
7,3,22.0,Fatigue,16293776
8,3,22.0,Dyspepsia,16293776
9,6,22.0,Nausea,16293776
10,6,22.0,Rectal haemorrhage,16293776
11,1,22.0,Stomatitis,16293776
12,6,22.0,Chest pain,16293776
13,2,22.0,Oral pain,16293776
14,3,22.0,Blood cholesterol increased,16293776
15,3,22.0,Gastrooesophageal reflux disease,16293776
16,6,22.0,Blood thyroid stimulating hormone abnormal,16293776
17,3,22.0,Decreased appetite,16293776
18,6,22.0,Cold sweat,16293776
19,6,22.0,Malaise,16293776
20,3,22.0,Gait disturbance,16293776
21,3,22.0,Peripheral swelling,16293776
0,1,22.1,Lhermitte^s sign,16294116
1,1,22.1,Facial nerve disorder,16294116
0,1,22.0,Pneumonia,16294467
0,6,22.0,No adverse event,16294726
1,6,22.0,Intentional product use issue,16294726
2,6,22.0,Off label use,16294726
0,1,22.0,Hypoglycaemia,16294819
0,3,22.0,Dysphonia,16295147
1,3,22.0,Diarrhoea,16295147
2,6,22.0,Off label use,16295147
3,6,22.0,Intentional product use issue,16295147
4,3,22.0,Flatulence,16295147
0,6,22.0,Leukopenia,16295276
0,1,22.0,Bone marrow failure,16295278
1,1,22.0,Bone marrow failure,16295278
2,6,22.0,Nausea,16295278
0,1,22.0,Cytopenia,16295321
0,1,22.0,Dyspnoea,16295362
1,1,22.0,Erythema,16295362
2,1,22.0,Chills,16295362
3,1,22.0,Rash papular,16295362
4,1,22.0,Anxiety,16295362
0,1,22.0,Anaphylactic shock,16295365
1,1,22.0,Oxygen saturation decreased,16295365
2,1,22.0,Hypotension,16295365
3,1,22.0,Chest discomfort,16295365
0,1,22.0,Erythema,16295378
1,1,22.0,Anxiety,16295378
2,1,22.0,Dyspnoea,16295378
0,6,22.0,Gastric cancer recurrent,16295386
1,6,22.0,Ascites,16295386
2,6,22.0,Metastatic neoplasm,16295386
0,6,22.0,Gastrointestinal disorder,16295405
0,3,22.0,Alopecia,16295532
1,6,22.0,Psychological trauma,16295532
0,2,22.1,Alopecia,16295534
1,6,22.1,Psychological trauma,16295534
0,2,22.0,Alopecia,16295537
1,6,22.0,Psychological trauma,16295537
0,6,22.0,Psychological trauma,16295564
1,2,22.0,Alopecia,16295564
0,6,22.0,Psychological trauma,16295600
1,2,22.0,Alopecia,16295600
0,2,22.0,Alopecia,16295603
0,2,22.0,Alopecia,16295609
0,3,22.0,Alopecia,16295626
1,6,22.0,Psychological trauma,16295626
0,6,22.0,Emotional distress,16295652
1,6,22.0,Impaired quality of life,16295652
2,6,22.0,Psychological trauma,16295652
3,2,22.0,Alopecia,16295652
4,6,22.0,Pain,16295652
5,6,22.0,Anxiety,16295652
0,3,22.0,Balance disorder,16295675
1,3,22.0,Muscular weakness,16295675
2,3,22.0,Gait disturbance,16295675
0,6,22.0,Psychological trauma,16295704
1,2,22.0,Alopecia,16295704
0,2,22.0,Alopecia,16295711
1,6,22.0,Psychological trauma,16295711
0,6,22.1,Psychological trauma,16295751
1,6,22.1,Anxiety,16295751
2,6,22.1,Pain,16295751
3,6,22.1,Impaired quality of life,16295751
4,2,22.1,Alopecia,16295751
5,6,22.1,Emotional distress,16295751
0,5,22.1,General physical health deterioration,16296012
1,5,22.1,Malignant neoplasm progression,16296012
2,3,22.1,Anaemia,16296012
3,3,22.1,Fatigue,16296012
0,4,22.0,Dysphagia,16296014
1,2,22.0,Back pain,16296014
0,2,22.0,Diarrhoea,16296047
1,2,22.0,Nausea,16296047
0,6,22.0,Impaired quality of life,16296084
1,6,22.0,Psychological trauma,16296084
2,6,22.0,Pain,16296084
3,2,22.0,Alopecia,16296084
4,6,22.0,Anxiety,16296084
5,6,22.0,Emotional distress,16296084
0,6,22.0,Hallucination,16296109
0,1,22.0,Bone pain,16296122
0,6,22.0,Oral pain,16296125
1,6,22.0,Aphasia,16296125
2,6,22.0,Rash,16296125
0,6,22.0,Pancytopenia,16296149
1,6,22.0,Arthralgia,16296149
0,1,22.0,White blood cell count decreased,16296189
1,6,22.0,Neoplasm progression,16296189
0,3,22.0,Alopecia,16296212
1,3,22.0,Madarosis,16296212
2,3,22.0,Hair disorder,16296212
3,3,22.0,Hair colour changes,16296212
4,3,22.0,Hair texture abnormal,16296212
0,3,22.0,Memory impairment,16296303
1,3,22.0,Hot flush,16296303
0,6,22.0,Ischaemia,16296325
1,6,22.0,Necrosis,16296325
2,6,22.0,Thrombosis,16296325
3,6,22.0,Ulcer,16296325
0,5,22.1,Peritonitis,16296384
1,3,22.1,Spinal pain,16296384
0,6,22.0,Dry skin,16296409
1,6,22.0,Skin tightness,16296409
2,6,22.0,Nasopharyngitis,16296409
3,6,22.0,Myalgia,16296409
4,6,22.0,Muscle spasms,16296409
5,6,22.0,Fatigue,16296409
0,3,22.0,Hair disorder,16296425
1,3,22.0,Hair colour changes,16296425
2,3,22.0,Hair texture abnormal,16296425
3,6,22.0,Depression,16296425
4,6,22.0,Sleep deficit,16296425
5,3,22.0,Alopecia,16296425
0,1,22.0,Hypersensitivity,16296481
1,1,22.0,Rash,16296481
0,3,22.0,Hair colour changes,16296489
1,3,22.0,Alopecia,16296489
2,3,22.0,Madarosis,16296489
3,3,22.0,Hair texture abnormal,16296489
4,3,22.0,Hair disorder,16296489
0,6,22.1,Headache,16296525
1,6,22.1,Immunodeficiency,16296525
2,6,22.1,Rash,16296525
3,6,22.1,White blood cell count decreased,16296525
4,6,22.1,Feelings of worthlessness,16296525
5,6,22.1,Alopecia,16296525
6,6,22.1,Pain,16296525
7,6,22.1,Asthenia,16296525
8,6,22.1,Tumour marker increased,16296525
9,6,22.1,Stomatitis,16296525
10,2,22.1,Fatigue,16296525
11,6,22.1,Malaise,16296525
12,6,22.1,Laboratory test abnormal,16296525
0,3,22.0,Hair disorder,16296536
1,3,22.0,Hair texture abnormal,16296536
2,3,22.0,Hair colour changes,16296536
3,3,22.0,Madarosis,16296536
4,3,22.0,Alopecia,16296536
0,6,22.0,Arthropathy,16296584
0,3,22.0,Hair disorder,16296588
1,3,22.0,Hair texture abnormal,16296588
2,3,22.0,Madarosis,16296588
3,3,22.0,Hair colour changes,16296588
4,3,22.0,Alopecia,16296588
0,3,22.1,Diarrhoea,16296603
1,1,22.1,Flatulence,16296603
0,3,22.0,Hair colour changes,16296608
1,6,22.0,Madarosis,16296608
2,6,22.0,Depression,16296608
3,3,22.0,Hair disorder,16296608
4,3,22.0,Hair texture abnormal,16296608
5,6,22.0,Alopecia,16296608
0,6,22.0,Diarrhoea,16296630
1,6,22.0,Decreased appetite,16296630
0,3,22.0,Alopecia,16296634
1,3,22.0,Hair disorder,16296634
2,3,22.0,Hair colour changes,16296634
3,3,22.0,Hair texture abnormal,16296634
0,1,22.0,Tachycardia,16296658
1,1,22.0,Hypomagnesaemia,16296658
2,6,22.0,Skin exfoliation,16296658
3,6,22.0,Dry skin,16296658
0,1,22.1,Colorectal cancer,16296725
1,1,22.1,Prostate cancer,16296725
2,6,22.1,B-cell small lymphocytic lymphoma,16296725
3,6,22.1,Metastases to liver,16296725
0,1,22.0,Disseminated Bacillus Calmette-Guerin infection,16296737
1,1,22.0,Device related infection,16296737
0,1,22.0,Vomiting,16296753
1,1,22.0,Malaise,16296753
2,1,22.0,Diarrhoea,16296753
3,1,22.0,Tremor,16296753
4,1,22.0,Feeling jittery,16296753
5,1,22.0,Infusion related reaction,16296753
6,1,22.0,Insomnia,16296753
7,1,22.0,Oropharyngeal pain,16296753
8,1,22.0,Abdominal pain,16296753
0,6,22.0,Transaminases increased,16296776
0,3,22.0,Thrombocytopenia,16296838
